News Focus
News Focus
Post# of 257268
Next 10
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

Re: jq1234 post# 114836

Tuesday, 10/11/2011 11:11:11 AM

Tuesday, October 11, 2011 11:11:11 AM

Post# of 257268
ViiV (i.e. GSK for all practical purposes) starts phase-3 trial of Selzentry+Prezista vs Truvada+Prezista:

http://finance.yahoo.com/news/ViiV-Healthcare-Starts-Phase-prnews-2842047759.html?x=0&.v=1

Selzentry is called ‘Censentri’ in Europe.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today